Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01029197 · ClinicalTrials.gov registry record · Phase 1

Multicomponent Cognitive Behavioral Therapy(CBT) for Posttraumatic Stress Disorder (PTSD) and Substance Abuse

A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
Phase 1
Development phase
45
Enrollment target

NCT01029197 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01029197, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
Phase 1
Development phase
45 participants
Enrollment target

Study Summary

Purpose: To conduct a pilot study of a cognitive-behavioral treatment (CBT) for PTSD and substance abuse among persons with serious mental illness (SMI) treated in a community setting. Participants: Participants will be 50 volunteer adult individuals with PTSD and substance use disorders (SUD), and SMI who are receiving services at the Freedom House Recovery Center, served through the Orange Person Chatham (OPC) Area Program. Procedures (methods): Participants will be randomly assigned to one of two conditions: 1) the CBT intervention plus treatment as usual; or, 2) treatment as usual.

Interventions

  • OTHER Treatment as Usual
  • BEHAVIORAL CBT and exposure therapy for PTSD

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2009-08
Est. Completion 2010-06
Phase Phase 1

What the Registry Record Tells You About NCT01029197

The ClinicalTrials.gov registry entry for NCT01029197 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT01029197 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01029197 about?

NCT01029197 is a clinical study titled "Multicomponent Cognitive Behavioral Therapy(CBT) for Posttraumatic Stress Disorder (PTSD) and Substance Abuse". Purpose: To conduct a pilot study of a cognitive-behavioral treatment (CBT) for PTSD and substance abuse among persons with serious mental illness (SMI) treated in a community setting. Participants: Participants will be 50 volunteer adult individuals with PTSD and substance use disorders (SUD), and...

What is the current status of trial NCT01029197?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2009-08. Estimated completion is 2010-06.

What interventions are being tested in trial NCT01029197?

The interventions under investigation include: Treatment as Usual (OTHER), CBT and exposure therapy for PTSD (BEHAVIORAL).

Who is sponsoring clinical trial NCT01029197?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.